260142
Vitamin D and Calcium Intake and Prevalent Periodontal Disease in Postmenopausal Women in the Osteoporosis and Periodontal Disease (OsteoPerio) Study, an ancillary study of the Women's Health Initiative Observational Study
Jean Wactawski-Wende, PhD
,
Department of Social and Preventive Medicine - School of Public Health and Professions, State University of New York at Buffalo, Buffalo, NY
Jo Freudenheim, PhD
,
Department of Social and Preventive Medicine, State University of New York at Buffalo, Buffalo, NY
Kathy Hovey, MS
,
Department of Social and Preventive Medicine - School of Public Health and Health Professions, State University of New York at Buffalo, Buffalo
Sonja Pavlesen, MD
,
Department of Social and Preventive Medicine, State University of New York at Buffalo, Buffalo, NY
Michael LaMonte, PhD, MPH
,
Department of Social and Preventive Medicine - School of Public Health and Professions, State University of New York at Buffalo, Buffalo, NY
Christopher Andrews, PhD
,
Department of Biostatistics, University at Buffalo, The State University of New York, Buffalo, NY
Robert Genco, PhD, DDS
,
Department of Oral Biology, State University of New York at Buffalo, Buffalo, NY
Amy Millen, PhD
,
Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, The State University of New York, Buffalo, NY
Background: Vitamin D (VitD) and calcium (Ca) are hypothesized to play important roles in reducing bone destruction in periodontal disease (PD). To our knowledge, we conducted the first large epidemiologic study investigating associations between PD, assessed by alveolar crestal height (ACH), and intake of these nutrients in women. Purpose: We investigated the cross-sectional association between intake of these nutrients and PD among 1,240 postmenopausal women in the Osteoporosis and Periodontal Disease (OsteoPerio) Study, an ancillary study of the Women's Health Initiative Observational Study (WHIOS). Methods: At WHIOS baseline (1994-1997), dietary and supplemental VitD (IU/day) and Ca (mg/day) intake were assessed using food frequency questionnaires and medication reviews. At OsteoPerio baseline (1997-2000), ACH was assessed from intraoral radiographs and used to define prevalence of any PD 941 (76%). Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for PD by category of nutrient intake. ORs were adjusted for age, hormone therapy use (HT), education, smoking, race and flossing frequency. Results: No significant associations were observed between PD and total VitD intake (OR (95%) for quintile 5(high) vs. 1(low)=1.20 (0.79-1.82); p-trend=0.25) or total Ca intake (0.82(0.53-1.26); p-trend=0.78). Results were similar when dietary and supplemental intakes were considered separately. Associations were not modified by sunlight exposure, smoking, age, HT, or body mass index. Findings did not differ by severity of PD. Conclusions: In this sample of generally healthy postmenopausal women with relatively normal VitD and Ca intakes, neither of these nutrient exposures were related with prevalent PD.
Learning Areas:
Chronic disease management and prevention
Epidemiology
Learning Objectives: Examine the cross-sectional association between periodontal disease (assessed with a measure of alveolar crestal height ) and vitamin D and calcium intake from foods and supplements in a cohort of postmenopausal women.
Assess whether the association between periodontal disease and total (diet plus supplement) intake of vitamin D and calcium differs according to age, sunlight exposure, smoking status, hormone therapy use, or body mass index.
Keywords: Oral Health, Epidemiology
Presenting author's disclosure statement:Qualified on the content I am responsible for because: Currently, I am a Masters of Science student in the Department of Social and Preventive Medicine at SUNY at Buffalo completing my Master's thesis. The material presented in the abstract was utilized for my thesis. The writing and data analysis on subject matter for abstract was completed primarily by me with the guidance and assistance of the co-authors.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|